The Library
Mortality on Mount Everest, 1921-2006 : descriptive study
Tools
Tools
Tools
Firth, P. G, Zheng, H., Windsor, J. S, Sutherland, A. I, Imray, C. (Chris), Moore, G W K, Semple, J. L, Roach, R. C and Salisbury, R. A (2008) Mortality on Mount Everest, 1921-2006 : descriptive study. BMJ, Vol.337 (No.1). a2654-a2654. doi:10.1136/bmj.a2654
Research output not available from this repository.
Request-a-Copy directly from author or use local Library Get it For Me service.
Official URL: http://dx.doi.org/10.1136/bmj.a2654
Abstract
Objective To examine patterns of mortality among climbers on Mount Everest over an 86 year period.
Design Descriptive study.
Setting Climbing expeditions to Mount Everest, 1921-2006.
Participants 14 138 mountaineers; 8030 climbers and 6108 sherpas.
Main outcome measure Circumstances of deaths.
Results The mortality rate among mountaineers above base camp was 1.3%. Deaths could be classified as involving trauma (objective hazards or falls, n=113), as non-traumatic (high altitude illness, hypothermia, or sudden death, n=52), or as a disappearance (body never found, n=27). During the spring climbing seasons from 1982 to 2006, 82.3% of deaths of climbers occurred during an attempt at reaching the summit. The death rate during all descents via standard routes was higher for climbers than for sherpas (2.7% (43/1585) v 0.4% (5/1231), P<0.001; all mountaineers 1.9%). Of 94 mountaineers who died after climbing above 8000 m, 53 (56%) died during descent from the summit, 16 (17%) after turning back, 9 (10%) during the ascent, 4 (5%) before leaving the final camp, and for 12 (13%) the stage of the summit bid was unknown. The median time to reach the summit via standard routes was earlier for survivors than for non-survivors (0900-0959 v 1300-1359, P<0.001). Profound fatigue (n=34), cognitive changes (n=21), and ataxia (n=12) were the commonest symptoms reported in non-survivors, whereas respiratory distress (n=5), headache (n=0), and nausea or vomiting (n=3) were rarely described.
Conclusions Debilitating symptoms consistent with high altitude cerebral oedema commonly present during descent from the summit of Mount Everest. Profound fatigue and late times in reaching the summit are early features associated with subsequent death.
| Item Type: | Journal Article | ||||
|---|---|---|---|---|---|
| Divisions: | Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School > Biomedical Sciences > Translational & Experimental Medicine > Metabolic and Vascular Health (- until July 2016) Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School |
||||
| Journal or Publication Title: | BMJ | ||||
| Publisher: | BMJ Publishing Group Ltd. | ||||
| ISSN: | 0959-535X | ||||
| Official Date: | 11 December 2008 | ||||
| Dates: |
|
||||
| Volume: | Vol.337 | ||||
| Number: | No.1 | ||||
| Page Range: | a2654-a2654 | ||||
| DOI: | 10.1136/bmj.a2654 | ||||
| Status: | Peer Reviewed | ||||
| Publication Status: | Published | ||||
| Access rights to Published version: | Restricted or Subscription Access |
Request changes or add full text files to a record
Repository staff actions (login required)
 |
View Item |
